Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie Traclet

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Respiration; International Review of Thoracic Diseases|April 10, 2019
A 2-Year Observational Study in Patients Suffering from Idiopathic Pulmonary Fibrosis and Treated with Pirfenidone: A French Ancillary Study of PASSPORTStéphane Jouneau, Anne-Sophie Gamez, Julie Traclet, et al.
Respiration; International Review of Thoracic Diseases|December 1, 2020
Impact of Lung Biopsy on Lung Function in Idiopathic Pulmonary FibrosisPierre-Henri Aussedat, Nader Chebib, Kais Ahmad, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 10, 2019
Cancer incidence in patients with pre-capillary pulmonary hypertensionElodie Bravos, Vincent Cottin, Claire Dauphin, et al.
Frontiers in Medicine|April 8, 2024
Mepolizumab and benralizumab in patients with severe asthma and a history of eosinophilic granulomatosis with polyangiitisCharlene Desaintjean, Kaïs Ahmad, Julie Traclet, et al.
The European Respiratory Journal|September 18, 2020
Progressive fibrosing interstitial lung disease: a clinical cohort (the PROGRESS study)Mouhamad Nasser, Sophie Larrieu, Salim Si-Mohamed, et al.
Journal of Clinical Medicine|January 11, 2025
Interstitial Lung Disease Associated with Anti-Ku Antibodies: A Case Series of 19 PatientsLaure Petitgrand, Kaïs Ahmad, Delphine Gamondès, et al.
Respiratory Research|November 8, 2023
Proteomic biomarkers for survival in systemic sclerosis-associated pulmonary hypertensionValentine Mismetti, Xavier Delavenne, David Montani, et al.
The European Respiratory Journal|September 14, 2018
Haemodynamics and serial risk assessment in systemic sclerosis associated pulmonary arterial hypertensionJason Weatherald, Athénaïs Boucly, David Launay, et al.
Respiratory Medicine and Research|April 23, 2026
Design of PROGRESSION-IPF: A pragmatic, open-label, randomized trial of patients with progressive disease in idiopathic pulmonary fibrosisVincent Cottin, Bruno Crestani, Carole Planès, et al.
The European Respiratory Journal|October 21, 2017
Management and long-term outcomes of sarcoidosis-associated pulmonary hypertensionAthénaïs Boucly, Vincent Cottin, Hilario Nunes, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Respiration; International Review of Thoracic Diseases|April 10, 2019
A 2-Year Observational Study in Patients Suffering from Idiopathic Pulmonary Fibrosis and Treated with Pirfenidone: A French Ancillary Study of PASSPORTStéphane Jouneau, Anne-Sophie Gamez, Julie Traclet, et al.
Respiration; International Review of Thoracic Diseases|December 1, 2020
Impact of Lung Biopsy on Lung Function in Idiopathic Pulmonary FibrosisPierre-Henri Aussedat, Nader Chebib, Kais Ahmad, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 10, 2019
Cancer incidence in patients with pre-capillary pulmonary hypertensionElodie Bravos, Vincent Cottin, Claire Dauphin, et al.
Frontiers in Medicine|April 8, 2024
Mepolizumab and benralizumab in patients with severe asthma and a history of eosinophilic granulomatosis with polyangiitisCharlene Desaintjean, Kaïs Ahmad, Julie Traclet, et al.
The European Respiratory Journal|September 18, 2020
Progressive fibrosing interstitial lung disease: a clinical cohort (the PROGRESS study)Mouhamad Nasser, Sophie Larrieu, Salim Si-Mohamed, et al.
Journal of Clinical Medicine|January 11, 2025
Interstitial Lung Disease Associated with Anti-Ku Antibodies: A Case Series of 19 PatientsLaure Petitgrand, Kaïs Ahmad, Delphine Gamondès, et al.
Respiratory Research|November 8, 2023
Proteomic biomarkers for survival in systemic sclerosis-associated pulmonary hypertensionValentine Mismetti, Xavier Delavenne, David Montani, et al.
The European Respiratory Journal|September 14, 2018
Haemodynamics and serial risk assessment in systemic sclerosis associated pulmonary arterial hypertensionJason Weatherald, Athénaïs Boucly, David Launay, et al.
Respiratory Medicine and Research|April 23, 2026
Design of PROGRESSION-IPF: A pragmatic, open-label, randomized trial of patients with progressive disease in idiopathic pulmonary fibrosisVincent Cottin, Bruno Crestani, Carole Planès, et al.
The European Respiratory Journal|October 21, 2017
Management and long-term outcomes of sarcoidosis-associated pulmonary hypertensionAthénaïs Boucly, Vincent Cottin, Hilario Nunes, et al.
Pageof 7